The Pharmaceutical Industry Environment

2001 ◽  
pp. 23-41
2021 ◽  
Vol 40 (1) ◽  
pp. 220-252
Author(s):  
Giovanni D’Orazio ◽  
Chiara Fanali ◽  
Chiara Dal Bosco ◽  
Alessandra Gentili ◽  
Salvatore Fanali

Abstract The determination and separation of enantiomers is an interesting and important topic of research in various fields, e.g., biochemistry, food science, pharmaceutical industry, environment, etc. Although these compounds possess identical physicochemical properties, a pair of enantiomers often has different pharmacological, toxicological, and metabolic activities. For this reason, chiral discrimination by using chromatographic and electromigration techniques has become an urgent need in the pharmaceutical field. This review intends to offer the “state of the art” about the separation of chiral antifungal drugs and several related precursors by both liquid and gas chromatography, as well as electromigration methods. This overview is organized into two sections. The first one describes general considerations on chiral antifungal drugs. The second part deals with the main analytical methods for the enantiomeric discrimination of these drugs, including a brief description of chiral selectors and stationary phases. Moreover, many recent applications attesting the great interest of analytical chemists in the field of enantiomeric separation are presented.


Author(s):  
Bing Zhao ◽  
Dong Sheng Zhang ◽  
Yong Zheng Zhao

Biological pharmaceutical industry not only has the continuous pulling action to region economy, also makes a positive contribution on the human productivity and quality of life. Biological pharmaceutical industry will become the leading industry of the century in quite a long time in the future. Taking Shijiazhuang as an example, according to the regional biopharmaceutical industry planning needs, building the industry competitiveness evaluation system, this paper analyzes the comparative advantage of Shijiazhuang in developing bio-pharmaceutical industry from 4 level evaluation index, including: the industry environment and policy, R & D capability, competitiveness of economic scale and industry support system. Provide a reference for local governments and business.


2015 ◽  
Vol 16 (1) ◽  
pp. 1-12
Author(s):  
Sharon Thach

The opening of China to foreign pharmaceutical companies created essentially a new market where the “rules of the game” were not previously established for the particular industrial setting. The regulations governing access to prescription drugs, the role of pharmaceuticals in providing funding for hospitals and clinics, and the low oversight of company practices resulted in a system of mutual corruption, high competition, and shifting regulatory and legal formalities. As the movement to open access to pharmaceuticals to non-hospital purveyors and the attention of Chinese authorities to certain industry practices has proceeded, the industry environment has changed significantly. Four possible new competitive models for pharmaceutical companies are evaluated.


Author(s):  
Bing Zhao ◽  
Dong Sheng Zhang ◽  
Yong Zheng Zhao

Biological pharmaceutical industry not only has the continuous pulling action to region economy, also makes a positive contribution on the human productivity and quality of life. Biological pharmaceutical industry will become the leading industry of the century in quite a long time in the future. Taking Shijiazhuang as an example, according to the regional biopharmaceutical industry planning needs, building the industry competitiveness evaluation system, this paper analyzes the comparative advantage of Shijiazhuang in developing bio-pharmaceutical industry from 4 level evaluation index, including: the industry environment and policy, R & D capability, competitiveness of economic scale and industry support system. Provide a reference for local governments and business.


2016 ◽  
Vol 2 (4) ◽  
pp. 234-241
Author(s):  
Mohammed Al-Shakka ◽  
Ebtesam Abood ◽  
Adel Al-Dhubhany ◽  
Sami Abdo Radman Aldubai ◽  
Khaled Said ◽  
...  

Because of the almost-instant connection with the welfare and well-being of individuals, pharmaceutical industry stands prominently as a very important factor for the improvement and progress of a healthy productive nation. These days, pharmaceutical industry thrives as one of the largest and exponentially expanding global industries. Nonetheless, millions of people in low income developing countries, have to suffer from the fatal consequences of the inaccessibility and non-availability of essential drugs. This is also happening in Yemen, where the pharmaceutical manufacturers sector have to face up to many challenges. The Yemen Drug Company (YEDCO) was founded in 1964 by the Yemeni government as it collaborated with private investors. It was endorsed as a company with the expertise in the medicinal drug marketing. YEDCO started its work by taking in drugs from foreign companies and then locally marketing and distributing them. In 1982, YEDCO built the first medicinal factory for drugs in Sana’a. Since then, seven companies were set up to manufacture medicines in Yemen. The expanding population has led to the need to have more pharmaceutical products. It may be understandable that pharmaceutical manufacturer companies are also hit by the political crisis in the country. Inadequate amount of fuel and raw material as well as low security status were some of the underlying factors behind these ill-effects in Yemen. Imported drugs make up about nearly 90% % of the pharmaceutical market compared to 10% drugs from the domestic market. This situation has led to an additional burden being shouldered by the national economy, where Yemen spends about US$263 million annually on pharmaceutical drugs, in reference to the national Supreme Drugs Authority. Although there is a very quick growth in the population and drugs consumption, the pharmaceutical industry has not been very active, where global pharmaceutical products play their role dominantly on the domestic market. The pharmaceutical production necessitates skilled human resources like university graduates. By contrast, the government and the private sector should also motivate the pharmaceutical industry and make use of the local employment


2011 ◽  
Vol 152 (47) ◽  
pp. 1894-1902
Author(s):  
János Antal ◽  
Attila Timár

Translational medicine is the emerging scientific discipline of the last decade which will set the benchmark for the pharmaceutical industry research and development, integrates inputs from the basic sciences of computer modeling and laboratory research through the pre-clinical and clinical phases of human research to the assimilation of new therapies and treatments into everyday practice of patient care and prevention. With this brief insight authors tried in their humble way to summarize the underlying basis, the present and the potential future of this emerging view, to draw attention to some of the challenges and tasks it faces and to highlight some of the promising approaches, trends and model developments and applications. Orv. Hetil., 2011, 152, 1894–1902.


Sign in / Sign up

Export Citation Format

Share Document